SCTB35 / Sinocelltech - LARVOL DELTA

SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1/2 | N=90 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P1/2 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (clinicaltrials.gov) - P3 | N=101 | Recruiting | Sponsor: Sinocelltech Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma (clinicaltrials.gov) - P3 | N=93 | Recruiting | Sponsor: Sinocelltech Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Oncology

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma (clinicaltrials.gov) - P3 | N=93 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P3 trial • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Oncology

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (clinicaltrials.gov) - P3 | N=101 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P3 trial • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology

A Study of SCTB35 in Patients with Systemic Lupus Erythematosus (clinicaltrials.gov) - P1/2 | N=168 | Recruiting | Sponsor: Sinocelltech Ltd.

New P1/2 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1 | N=76 | Not yet recruiting | Sponsor: Sinocelltech Ltd.

New P1 trial • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology